Showing results (6831-6840 of 14,264) with videos related to
Sort By:
Pageof 1,427
Diabetes|May 23, 2014
Orally active osteoanabolic agent GTDF binds to adiponectin receptors, with a preference for AdipoR1, induces adiponectin-associated signaling, and improves metabolic health in a rodent model of diabetesAbhishek Kumar Singh, Amit Arvind Joharapurkar, Mohd Parvez Khan, et al.Diabetes|May 23, 2014
Mangiferin stimulates carbohydrate oxidation and protects against metabolic disorders induced by high-fat dietsPasha Apontes, Zhongbo Liu, Kai Su, et al.Diabetes|May 23, 2014
Inhibition of JNK phosphorylation by a novel curcumin analog prevents high glucose-induced inflammation and apoptosis in cardiomyocytes and the development of diabetic cardiomyopathyYong Pan, Yi Wang, Yunjie Zhao, et al.Diabetes|June 17, 2014
Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI?Geert Jan Biessels, Yael D ReijmerDiabetes|June 17, 2014
Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer diseaseFernanda G De Felice, Sergio T FerreiraDiabetes|June 19, 2014
Coinfusion of low-dose GLP-1 and glucagon in man results in a reduction in food intakeJaimini Cegla, Rachel C Troke, Ben Jones, et al.Diabetes|June 21, 2014
SIRT1 mediates the effect of GLP-1 receptor agonist exenatide on ameliorating hepatic steatosisFen Xu, Zhuo Li, Xiaobin Zheng, et al.Diabetes|June 21, 2014
Fractalkine (CX3CL1) is involved in the early activation of hypothalamic inflammation in experimental obesityJoseane Morari, Gabriel F Anhe, Lucas F Nascimento, et al.Diabetes|June 21, 2014
White matter integrity disruptions associated with cognitive impairments in type 2 diabetic patientsJunying Zhang, Yunxia Wang, Jun Wang, et al.Diabetes|June 21, 2014
Peroxiredoxin 6, a novel player in the pathogenesis of diabetesFrancesca Pacifici, Roberto Arriga, Gian Pio Sorice, et al.Pageof 1,427